We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Revolutionary Glucose Monitoring System Receives CE Marking

By LabMedica International staff writers
Posted on 29 Sep 2014
Print article
The Abbott Diabetes Care FreeStyle Libre Flash Glucose Monitoring System
The FreeStyle Libre Flash Glucose Monitoring System (Photo courtesy of ABBOTT Corporate)
A revolutionary new glucose sensing technology, which eliminates the need for routine finger pricks, has received Conformité Européenne (CE) marking.

The system measures glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days and in addition, no finger prick calibration is needed, a key differentiator from current continuous glucose monitoring systems.

The FreeStyle Libre Flash Glucose Monitoring System (Abbott Diabetes Care; Alameda, CA, USA) consists of a small, round sensor worn on the back of the upper arm, which measures glucose every minute in interstitial fluid through a small, 5-mm long, 0.4-mm wide filament that is inserted just under the skin and held in place with a small adhesive pad. A reader is scanned over the sensor to get a glucose result painlessly in less than one second. Scanning can take place while the sensor is under clothing, making testing more discreet and convenient and each scan displays a real-time glucose result, a historical trend, and the direction the glucose is heading.

The reader holds up to 90 days of data, providing a historical snapshot of glucose levels over time. The FreeStyle Libre System software enables the data to be presented in a user-friendly, visual chart for both healthcare professionals and patients, driving a more productive discussion around treatment and any necessary modification. A recent study conducted by Abbott has shown that the FreeStyle Libre System is clinically proven to be accurate, stable and consistent over 14 days without the need for finger prick calibration. The FreeStyle Libre System provides users and their physicians with the Ambulatory Glucose Profile (AGP), a report providing a visual snapshot of a person′s typical day by utilizing dense glucose data revealing hypoglycemic and hyperglycemic trends to facilitate better patient therapy and education. The system will be available in seven countries across Europe in the coming weeks.

Clifford J. Bailey, PhD, FRCP, FRCPath, a professor of Clinical Science and Director of Biomedical Sciences Research at Aston University (Birmingham, UK), said, “For decades, people with diabetes have had to prick their fingers routinely to check their glucose levels. The pain and inconvenience of finger pricks has contributed to less frequent testing and suboptimal diabetes management. By eliminating the need for routine finger pricks, the FreeStyle Libre System will significantly advance the field of glucose monitoring. It offers a convenient and painless way to get more frequent glucose readings, which should help to improve diabetes management.” The study details were presented at the at the Abbott Symposium at the European Association for the Study of Diabetes (EASD) medical conference held September 15–19, 2014, in Vienna (Austria).

Related Links:

Abbott Diabetes Care
Aston University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.